Hrt Financial LP I Bio, Inc. Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.23 - $160.0 $25,135 - $17.5 Million
-109,283 Reduced 75.62%
35,232 $6,000
Q2 2022

Aug 12, 2022
BUY
$0.23 - $0.46 $33,238 - $66,476
144,515 New
144,515 $38,000
Q4 2021

Feb 14, 2022
SELL
$0.55 - $1.04 $5,993 - $11,333
-10,898 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.06 - $1.52 $11,551 - $16,564
10,898 New
10,898 $11,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email